A study by consulting firm Accenture shows that patients not only expect digital outreach, but that their desire to be engaged is consistently being ignored.
The FDA's bad-ad unit took a drugmaker to task for what it calls a misleading Facebook page. History shows the social media surveillance should take no one by surprise.
The physician networking service rolled out a job-hunting service that brings the medical job search into the modern age and provides a revenue stream.
The company has partnered with Univision on a dance competition that supports health and weight loss. The segment, called Ritmo Dieta, will run for 13 weeks on the variety program Sábado Gigante.
Execs told Weber Shandwick that internal hurdles such as insufficient expertise and unclear ROI measures are really what's keeping them from the social-media mix.
Gwee, who pioneered pharma social media at Vertex before moving onto the agency side, is tasked with integrating digital and social strategies across the marketing and PR network's 14 agencies.
Google's latest YouTube update aims to make its Channels more social, and even as the company has given its pharma clients an extra month to hold on to their old page designs, the new format is inspiring anxiety among drug firms and medical agencies.
The Mondays Campaign is expanding its smoking cessation efforts to include social media outreach. Program director Cherry Dumaual tells MM&M social media helps quitters know someone has their back.
A new app from ViroPharma seeks to leverage a social forum to both raise awareness of a rare disease and provide access to important disease and treatment information.
A new algorithm gives Diabetes Nest a higher level of Tweet curation. The architect notes this doesn't mean the feed will be about glucose levels and adherence.
There have been multiple promises by pharma to change its sales and marketing approach. Booz & Co. partner Danielle Rollmann says the time for promises is over, and action needs to happen, particularly in the digital space. Now.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.